Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
WallStreetSelect 114
WallStreetSelect 114
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Organon & Co. Common Stock
(NY:
OGN
)
7.925
+0.015 (+0.19%)
Streaming Delayed Price
Updated: 1:40 PM EST, Feb 10, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
1,848,500
Open
7.910
Bid (Size)
7.920 (4,600)
Ask (Size)
7.930 (2,200)
Prev. Close
7.910
Today's Range
7.855 - 8.000
52wk Range
6.180 - 17.23
Shares Outstanding
259,965,579
Dividend Yield
1.01%
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
2 Healthcare Stocks with Promising Prospects and 1 We Brush Off
February 04, 2026
From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. Those leading the charge have not only realized strong financial performance but...
Via
StockStory
Topics
Stocks
Organon To Report Fourth Quarter and Full Year 2025 Results and Host Conference Call on February 12, 2026
January 29, 2026
From
Organon & Co.
Via
Business Wire
Performance
YTD
+9.5%
+9.5%
1 Month
-2.4%
-2.4%
3 Month
+2.8%
+2.8%
6 Month
-12.0%
-12.0%
1 Year
-47.3%
-47.3%
More News
Read More
Organon Completes Divestiture of JADA® System to Laborie
January 28, 2026
From
Organon & Co.
Via
Business Wire
The Post-Keytruda Pivot: Inside Merck’s Strategic Evolution and the RVMD Landscape
January 26, 2026
Via
Finterra
Topics
Artificial Intelligence
Economy
Intellectual Property
Stability Meets Scale: Why Johnson & Johnson is Poised for a Breakout 2026
January 23, 2026
Via
MarketMinute
Topics
Artificial Intelligence
Bankruptcy
Economy
Nasdaq, S&P 500 Futures Rise As Trump Diffuses Tariff Risk: Why INTC, MSFT, NFLX, RKLB, OGN Are On Traders' Radar Today
↗
January 22, 2026
Via
Stocktwits
Topics
ETFs
Earnings
Economy
Why Are Organon (OGN) Shares Soaring Today
January 20, 2026
Via
StockStory
Topics
Artificial Intelligence
Initial Public Offering
Supply Chain
Organon Announces US Food and Drug Administration Approval of Supplemental New Drug Application Extending Duration of Use of NEXPLANON® (etonogestrel implant) 68 mg Radiopaque
January 16, 2026
From
Organon & Co.
Via
Business Wire
3 Small-Cap Stocks We Approach with Caution
January 07, 2026
Via
StockStory
3 Healthcare Stocks with Questionable Fundamentals
December 15, 2025
Via
StockStory
Topics
Stocks
Why Organon (OGN) Shares Are Trading Lower Today
December 09, 2025
Via
StockStory
Topics
Initial Public Offering
3 Stocks Under $10 We Steer Clear Of
December 08, 2025
Via
StockStory
3 Value Stocks with Questionable Fundamentals
December 04, 2025
Via
StockStory
3 Cash-Producing Stocks We Find Risky
December 03, 2025
Via
StockStory
Organon (OGN): Buy, Sell, or Hold Post Q3 Earnings?
November 30, 2025
Via
StockStory
Topics
Stocks
Q3 Rundown: Organon (NYSE:OGN) Vs Other Branded Pharmaceuticals Stocks
November 25, 2025
Via
StockStory
Topics
Artificial Intelligence
Intellectual Property
Organon To Present at the Piper Sandler 37th Annual Healthcare Conference
November 25, 2025
From
Organon & Co.
Via
Business Wire
Henlius and Organon Announce US FDA Approval of POHERDY® (pertuzumab-dpzb), the First PERJETA (pertuzumab) Biosimilar in the US
November 17, 2025
From
Organon & Co.
Via
Business Wire
The 5 Most Interesting Analyst Questions From Organon’s Q3 Earnings Call
November 17, 2025
Via
StockStory
Topics
Earnings
Organon Investigation Initiated By Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates Claims On Behalf of Investors of Organon & Co. - OGN
November 14, 2025
From
Kahn Swick & Foti, LLC
Via
Business Wire
Organon (OGN) Stock Trades Down, Here Is Why
November 11, 2025
Via
StockStory
Topics
Artificial Intelligence
Initial Public Offering
Supply Chain
Organon Analysts Cut Their Forecasts Following Q3 Results
↗
November 11, 2025
Via
Benzinga
OGN Q3 2025 Deep Dive: Leadership Changes, Portfolio Shifts, and Guidance Recalibration
November 11, 2025
Via
StockStory
Tech Rallies, Palantir Jumps 6% As Shutdown End Looms: What's Moving Markets Monday?
↗
November 10, 2025
Via
Benzinga
Organon Cuts 2025 Sales Outlook Despite Earnings Beat
↗
November 10, 2025
Via
Benzinga
Frequently Asked Questions
Is Organon & Co. Common Stock publicly traded?
Yes, Organon & Co. Common Stock is publicly traded.
What exchange does Organon & Co. Common Stock trade on?
Organon & Co. Common Stock trades on the New York Stock Exchange
What is the ticker symbol for Organon & Co. Common Stock?
The ticker symbol for Organon & Co. Common Stock is OGN on the New York Stock Exchange
What is the current price of Organon & Co. Common Stock?
The current price of Organon & Co. Common Stock is 7.925
When was Organon & Co. Common Stock last traded?
The last trade of Organon & Co. Common Stock was at 02/10/26 01:40 PM ET
What is the market capitalization of Organon & Co. Common Stock?
The market capitalization of Organon & Co. Common Stock is 2.06B
How many shares of Organon & Co. Common Stock are outstanding?
Organon & Co. Common Stock has 2B shares outstanding.
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
